wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38819164-3D8E1027-55B8-40CA-8320-41425F7CC503
Q38819164-3D8E1027-55B8-40CA-8320-41425F7CC503
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38819164-3D8E1027-55B8-40CA-8320-41425F7CC503
Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets.
P2860
Q38819164-3D8E1027-55B8-40CA-8320-41425F7CC503
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38819164-3D8E1027-55B8-40CA-8320-41425F7CC503
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
73ba5bb9c6c346d3485c02ebce0a1f028f1aa5dc
P2860
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies